Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 436

    1.

    The benefits of flexible team interaction during crises.

    Stachowski AA, Kaplan SA, Waller MJ.

    J Appl Psychol. 2009 Nov;94(6):1536-43.PMID: 19916660 [PubMed - in process]Related articles

    2.

    The economic impact of work and family issues: child care satisfaction and financial considerations of employed mothers.

    Poms LW, Botsford WE, Kaplan SA, Buffardi LC, O'Brien AS.

    J Occup Health Psychol. 2009 Oct;14(4):402-13.PMID: 19839660 [PubMed - in process]Related articles

    3.

    Safety and tolerability of solifenacin add-on therapy to alpha-blocker treated men with residual urgency and frequency.

    Kaplan SA, McCammon K, Fincher R, Fakhoury A, He W.

    J Urol. 2009 Dec;182(6):2825-30. Epub 2009 Oct 17.PMID: 19837435 [PubMed - in process]Related articles

    4.

    Should testosterone replacement be given to men with large prostates?

    Marks LS, Kaplan SA.

    J Urol. 2009 Nov;182(5):2109-11. Epub 2009 Sep 16. No abstract available. PMID: 19758636 [PubMed - indexed for MEDLINE]Related articles

    5.

    The viability of community partnerships initiated by external funders.

    Berry C, Kaplan SA, Reid A, Albert S.

    Public Health Rep. 2009 Jul-Aug;124(4):590-3. No abstract available. PMID: 19618797 [PubMed - indexed for MEDLINE]Related articles

    6.

    Association of lower urinary tract symptoms and the metabolic syndrome: results from the Boston Area Community Health Survey.

    Kupelian V, McVary KT, Kaplan SA, Hall SA, Link CL, Aiyer LP, Mollon P, Tamimi N, Rosen RC, McKinlay JB.

    J Urol. 2009 Aug;182(2):616-24; discussion 624-5. Epub 2009 Jun 18.PMID: 19539955 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Temporal trends in adoption of and indications for the artificial urinary sphincter.

    Lee R, Te AE, Kaplan SA, Sandhu JS.

    J Urol. 2009 Jun;181(6):2622-7. Epub 2009 Apr 16.PMID: 19375102 [PubMed - indexed for MEDLINE]Related articles

    8.

    Variation in institutional review board responses to a standard protocol for a multicenter randomized, controlled surgical trial.

    Helfand BT, Mongiu AK, Roehrborn CG, Donnell RF, Bruskewitz R, Kaplan SA, Kusek JW, Coombs L, McVary KT; MIST Investigators.

    J Urol. 2009 Jun;181(6):2674-9. Epub 2009 Apr 16.PMID: 19375101 [PubMed - indexed for MEDLINE]Related articles

    9.

    Implications of recent epidemiology studies for the clinical management of lower urinary tract symptoms.

    Kaplan SA, Roehrborn CG, Chapple CR, Rosen RC, Irwin DE, Kopp Z, Aiyer LP, Mollon P.

    BJU Int. 2009 Apr;103 Suppl 3:48-57.PMID: 19302502 [PubMed - indexed for MEDLINE]Related articles

    10.

    Risk factors and comorbid conditions associated with lower urinary tract symptoms: EpiLUTS.

    Coyne KS, Kaplan SA, Chapple CR, Sexton CC, Kopp ZS, Bush EN, Aiyer LP; EpiLUTS Team.

    BJU Int. 2009 Apr;103 Suppl 3:24-32.PMID: 19302499 [PubMed - indexed for MEDLINE]Related articles

    11.

    Lower urinary tract symptoms: new perspectives on prevalence, burden and comorbidities. Introduction.

    Chapple CR, Kaplan SA.

    BJU Int. 2009 Apr;103 Suppl 3:1-3. No abstract available. PMID: 19302496 [PubMed - indexed for MEDLINE]Related articles

    12.

    PCPT: Evidence that finasteride reduces risk of most frequently detected intermediate- and high-grade (Gleason score 6 and 7) cancer.

    Kaplan SA, Roehrborn CG, Meehan AG, Liu KS, Carides AD, Binkowitz BS, Heyden NL, Vaughan ED Jr.

    Urology. 2009 May;73(5):935-9. Epub 2009 Mar 28.PMID: 19328538 [PubMed - indexed for MEDLINE]Related articles

    13.

    A new vision for the study of benign prostate disease: the NIDDK Prostate Research Strategic Plan.

    Mullins C, Kaplan SA.

    J Urol. 2009 Mar;181(3):963-71. Epub 2009 Jan 16.PMID: 19150562 [PubMed - indexed for MEDLINE]Related articles

    14.

    Association of urological symptoms and chronic illness in men and women: contributions of symptom severity and duration--results from the BACH Survey.

    Kupelian V, Rosen RC, Link CL, McVary KT, Aiyer LP, Mollon P, Kaplan SA, McKinlay JB.

    J Urol. 2009 Feb;181(2):694-700. Epub 2008 Dec 16.PMID: 19091335 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Current role of alpha-blockers in the treatment of benign prostatic hyperplasia.

    Kaplan SA.

    BJU Int. 2008 Nov;102 Suppl 2:3-7. Review. No abstract available. PMID: 19032603 [PubMed - indexed for MEDLINE]Related articles

    16.

    Special Issue: Current practices in the management of benign prostatic hyperplasia. Introduction.

    Roehrborn CG, Kaplan SA.

    BJU Int. 2008 Nov;102 Suppl 2:1-2. No abstract available. PMID: 19032602 [PubMed - indexed for MEDLINE]Related articles

    17.

    Voiding dysfunction in men: pathophysiology and risk factors.

    Scofield S, Kaplan SA.

    Int J Impot Res. 2008 Dec;20 Suppl 3:S2-10. Review. No abstract available. PMID: 19002121 [PubMed - indexed for MEDLINE]Related articles

    18.

    Introduction: BPH and sexual dysfunction--recommendations for the primary care physician and urologist.

    Kaplan SA.

    Int J Impot Res. 2008 Dec;20 Suppl 3:S1. No abstract available. PMID: 19002118 [PubMed - indexed for MEDLINE]Related articles

    19.

    Effects of serum PSA on efficacy of tolterodine extended release with or without tamsulosin in men with LUTS, including OAB.

    Roehrborn CG, Kaplan SA, Kraus SR, Wang JT, Bavendam T, Guan Z.

    Urology. 2008 Nov;72(5):1061-7; discussion 1067. Epub 2008 Sep 25.PMID: 18817961 [PubMed - indexed for MEDLINE]Related articles

    20.

    Long-term treatment with finasteride results in a clinically significant reduction in total prostate volume compared to placebo over the full range of baseline prostate sizes in men enrolled in the MTOPS trial.

    Kaplan SA, Roehrborn CG, McConnell JD, Meehan AG, Surynawanshi S, Lee JY, Rotonda J, Kusek JW, Nyberg LM Jr; Medical Therapy of Prostatic Symptoms Research Group.

    J Urol. 2008 Sep;180(3):1030-2; discussion 1032-3. Epub 2008 Jul 17.PMID: 18639298 [PubMed - indexed for MEDLINE]Related articles

    21.

    Effect of tolterodine extended release with or without tamsulosin on measures of urgency and patient reported outcomes in men with lower urinary tract symptoms.

    Rovner ES, Kreder K, Sussman DO, Kaplan SA, Carlsson M, Bavendam T, Guan Z.

    J Urol. 2008 Sep;180(3):1034-41. Epub 2008 Jul 17.PMID: 18639297 [PubMed - indexed for MEDLINE]Related articles

    22.

    Tolterodine extended release with or without tamsulosin in men with lower urinary tract symptoms including overactive bladder symptoms: effects of prostate size.

    Roehrborn CG, Kaplan SA, Jones JS, Wang JT, Bavendam T, Guan Z.

    Eur Urol. 2009 Feb;55(2):472-9. Epub 2008 Jun 17.PMID: 18583022 [PubMed - indexed for MEDLINE]Related articles

    23.

    Extended-release tolterodine with or without tamsulosin in men with lower urinary tract symptoms and overactive bladder: effects on urinary symptoms assessed by the International Prostate Symptom Score.

    Kaplan SA, Roehrborn CG, Chancellor M, Carlsson M, Bavendam T, Guan Z.

    BJU Int. 2008 Nov;102(9):1133-9. Epub 2008 May 26.PMID: 18510659 [PubMed - indexed for MEDLINE]Related articles

    24.

    Transurethral resection of the prostate--is our gold standard still a precious commodity?

    Kaplan SA.

    J Urol. 2008 Jul;180(1):15-6. Epub 2008 May 15. No abstract available. PMID: 18485411 [PubMed - indexed for MEDLINE]Related articles

    25.

    Urinary retention and post-void residual urine in men: separating truth from tradition.

    Kaplan SA, Wein AJ, Staskin DR, Roehrborn CG, Steers WD.

    J Urol. 2008 Jul;180(1):47-54. Epub 2008 May 15. Review.PMID: 18485378 [PubMed - indexed for MEDLINE]Related articles

    26.

    Inside the virtual casino: a prospective longitudinal study of actual Internet casino gambling.

    Labrie RA, Kaplan SA, Laplante DA, Nelson SE, Shaffer HJ.

    Eur J Public Health. 2008 Aug;18(4):410-6. Epub 2008 Apr 23.PMID: 18434382 [PubMed - indexed for MEDLINE]Related articlesFree article

    27.

    Commentary on holmium laser enucleation versus TURP.

    Kaplan SA.

    J Urol. 2008 May;179(5 Suppl):S91. No abstract available. PMID: 18405766 [PubMed - indexed for MEDLINE]Related articles

    28.

    Tolterodine extended release attenuates lower urinary tract symptoms in men with benign prostatic hyperplasia.

    Kaplan SA, Walmsley K, Te AE.

    J Urol. 2008 May;179(5 Suppl):S82-5.PMID: 18405763 [PubMed]Related articles

    29.

    Lower urinary tract symptoms revisited: a broader clinical perspective.

    Chapple CR, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT, Roehrborn CG.

    Eur Urol. 2008 Sep;54(3):563-9. Epub 2008 Apr 8. Review.PMID: 18423969 [PubMed - indexed for MEDLINE]Related articles

    30.

    Beyond the cluster: methodological and clinical implications in the Boston Area Community Health survey and EPIC studies.

    Rosen RC, Coyne KS, Henry D, Link CL, Cinar A, Aiyer LP, Mollon P, Kaplan SA, Roehrborn CG, Thompson C.

    BJU Int. 2008 May;101(10):1274-8.PMID: 18419700 [PubMed - indexed for MEDLINE]Related articles

    31.

    Do urological symptoms cluster among women? Results from the Boston Area Community Health Survey.

    Hall SA, Cinar A, Link CL, Kopp ZS, Roehrborn CG, Kaplan SA, Rosen RC.

    BJU Int. 2008 May;101(10):1257-66.PMID: 18419699 [PubMed - indexed for MEDLINE]Related articles

    32.

    Cluster analysis and lower urinary tract symptoms in men: findings from the Boston Area Community Health Survey.

    Cinar A, Hall SA, Link CL, Kaplan SA, Kopp ZS, Roehrborn CG, Rosen RC.

    BJU Int. 2008 May;101(10):1247-56.PMID: 18419698 [PubMed - indexed for MEDLINE]Related articles

    33.

    The influence of television on willingness to seek therapy.

    Vogel DL, Gentile DA, Kaplan SA.

    J Clin Psychol. 2008 Mar;64(3):276-95.PMID: 18271003 [PubMed - indexed for MEDLINE]Related articles

    34.

    The somatomedin hypothesis 2007: 50 years later.

    Kaplan SA, Cohen P.

    J Clin Endocrinol Metab. 2007 Dec;92(12):4529-35. Epub 2007 Nov 6. Review.PMID: 17986643 [PubMed - indexed for MEDLINE]Related articlesFree article

    35.

    Conducting multilevel analyses in medical education.

    Zyphur MJ, Kaplan SA, Islam G, Barsky AP, Franklin MS.

    Adv Health Sci Educ Theory Pract. 2008 Dec;13(5):571-82. Epub 2007 Oct 12.PMID: 17932779 [PubMed - indexed for MEDLINE]Related articles

    36.

    Open to debate. The motion: PDE5 inhibitors will have a significant role in the treatment of BPH.

    Kaplan SA, Hatzichristou D.

    Eur Urol. 2007 Nov;52(5):1523-7. Epub 2007 Aug 22. Review. No abstract available. PMID: 17728048 [PubMed - indexed for MEDLINE]Related articles

    37.

    The pituitary gland: a brief history.

    Kaplan SA.

    Pituitary. 2007;10(4):323-5.PMID: 17690988 [PubMed - indexed for MEDLINE]Related articles

    38.

    [The role of muscarinic receptor antagonists in the treatment of men with lower urinary tract symptoms secondary to BPH]

    Kaplan SA.

    Actas Urol Esp. 2007 Feb;31(2):86-91. Review. Spanish. PMID: 17645086 [PubMed - indexed for MEDLINE]Related articlesFree article

    39.

    A practical guide to the evaluation and treatment of male lower urinary tract symptoms in the primary care setting.

    Rosenberg MT, Staskin DR, Kaplan SA, MacDiarmid SA, Newman DK, Ohl DA.

    Int J Clin Pract. 2007 Sep;61(9):1535-46. Epub 2007 Jul 11. Review.PMID: 17627768 [PubMed - indexed for MEDLINE]Related articlesFree article

    41.

    Phosphodiesterase type 5 inhibitors for the treatment of male lower urinary tract symptoms.

    Kaplan SA, Gonzalez RR.

    Rev Urol. 2007 Spring;9(2):73-7.PMID: 17592540 [PubMed - in process]Related articlesFree article

    42.

    Metabolic dysfunction and male pelvic health.

    Kaplan SA.

    Eur Urol. 2007 Aug;52(2):316-7. Epub 2007 Apr 3. No abstract available. PMID: 17452073 [PubMed - indexed for MEDLINE]Related articles

    43.

    Combination of alfuzosin and sildenafil is superior to monotherapy in treating lower urinary tract symptoms and erectile dysfunction.

    Kaplan SA, Gonzalez RR, Te AE.

    Eur Urol. 2007 Jun;51(6):1717-23. Epub 2007 Jan 16. Erratum in: Eur Urol. 2008 Jun;53(6):1320. PMID: 17258855 [PubMed - indexed for MEDLINE]Related articles

    44.

    If you feel bad, it's unfair: a quantitative synthesis of affect and organizational justice perceptions.

    Barsky A, Kaplan SA.

    J Appl Psychol. 2007 Jan;92(1):286-95.PMID: 17227170 [PubMed - indexed for MEDLINE]Related articles

    46.

    Expanding the role of photoselective vaporization of the prostate.

    Kaplan SA.

    Rev Urol. 2006;8 Suppl 3:S3-8.PMID: 17173100 [PubMed - in process]Related articlesFree article

    47.

    The effects of nicotinamide on apoptosis and blood-brain barrier breakdown following traumatic brain injury.

    Hoane MR, Kaplan SA, Ellis AL.

    Brain Res. 2006 Dec 13;1125(1):185-93. Epub 2006 Nov 14.PMID: 17109832 [PubMed - indexed for MEDLINE]Related articles

    48.

    Tolterodine and tamsulosin for treatment of men with lower urinary tract symptoms and overactive bladder: a randomized controlled trial.

    Kaplan SA, Roehrborn CG, Rovner ES, Carlsson M, Bavendam T, Guan Z.

    JAMA. 2006 Nov 15;296(19):2319-28. Erratum in: JAMA. 2007 Mar 21:297(11):1195. JAMA. 2007 Oct 24;298(16):1864. PMID: 17105794 [PubMed - indexed for MEDLINE]Related articlesFree article

    49.

    Male pelvic health: a urological call to arms.

    Kaplan SA.

    J Urol. 2006 Dec;176(6 Pt 1):2351-2. No abstract available. PMID: 17085100 [PubMed - indexed for MEDLINE]Related articles

    50.

    Antimuscarinic therapy in men with bladder outlet obstruction.

    Staskin DR, Kaplan SA, Wein AJ.

    Curr Urol Rep. 2006 Nov;7(6):437-9. No abstract available. PMID: 17052436 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...